Citation Impact
Citing Papers
Clinical Pharmacokinetics of Cyclophosphamide
1979
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Cyclophosphamide and related anticancer drugs
2001
Intranasal Azelastine
1998
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes
1999
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
2009
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Clinical Pharmacokinetics of Cyclophosphamide
1991
Antibiotics in the aquatic environment – A review – Part I
2009 Standout
Clinical Pharmacology of New Histamiine H1 Receptor Antagonists
1999
Drug development from marine natural products
2008 Standout
Antioxidant and Prooxidant Activities of α-Lipoic Acid and Dihydrolipoic Acid
2002
Protein Oxidation in Aging, Disease, and Oxidative Stress
1997 Standout
Central nervous system effects of H1-receptor antagonists in the elderly
1999
The effect of ionizing radiation on lipid membranes
1991
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Restoration of Dioxin-Induced Damage to Fetal Steroidogenesis and Gonadotropin Formation by Maternal Co-Treatment with α-Lipoic Acid
2012
Long-term safety of α-lipoic acid (ALA) consumption: A 2-year study
2006
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)
1999 StandoutNobel
α-Lipoic Acid and Cardiovascular Disease
2003
(R)-α-Lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis
2004
Analysis of anticancer drugs: A review
2011 Standout
Principles and practice of DNA filter elution
1991 StandoutNobel
TAXI/UAS: A Molecular Switch to Control Expression of Genes In Vivo
1996 StandoutNobel
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
2010 Standout
The role of glutathione in cancer
2004
Targeting lipoic acid to mitochondria: Synthesis and characterization of a triphenylphosphonium-conjugated α-lipoyl derivative
2007
Lipid peroxidation: its mechanism, measurement, and significance
1993 Standout
Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anti-cancer agent kahalalide F
2001
Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation
1992
Free radical-mediated oxidation of free amino acids and amino acid residues in proteins
2003 Standout
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
Chronic systemic D‐galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: Protective effects of R‐α‐lipoic acid
2006 Standout
Mutagenic, teratogenic and pharmacokinetic properties of cyclophosphamide and some of its deuterated derivatives
1982
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
Protein Oxidation and Aging
1992 StandoutScience
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
A critical review of the literature on acrolein toxicity
1985
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
Oxygen Effect in the Radiolysis of Proteins
1984
Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
1982
Photolabile Carbonyl Protecting Group: A New Tool for Light‐Controlled Release of Anticancer Agents
2009
Medicinal and pharmaceutical uses of seaweed natural products: A review
2004 Standout
Arzneimittelentwicklung: Die Reduzierung von Umweltbelastungen durch gezieltes Moleküldesign
2008
Modulation of cyclophosphamide activity by O ? 6 -alkylguanine-DNA alkyltransferase
1999 StandoutNobel
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Formation, toxicity and inactivation of acrolein during biotransformation of cyclophosphamide as studied in freshly isolated cells from rat liver and kidney
1985
Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and green chemistry
2007
Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
1986
Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
1980 StandoutNobel
Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
1986
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
1989 Science
Invited Review: Total Parenteral Nutritional Support of Patients With Acute Renal Failure
1988
Alternative Synthetic Methods through New Developments in Catalysis by Gold
2008 Standout
A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in Nurses
1985 Standout
A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC).
1995 StandoutNobel
Protein damage and degradation by oxygen radicals. I. general aspects.
1987 Standout
X- and γ-radiolysis of Some Tryptophan Dipeptides
1970
Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.
1981
Metabolism of oxazaphosphorines
1988
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells
1984
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
1995 Standout
Works of G. Peter being referenced
Characterization and quantitative estimation of activated cyclophosphamide in blood and urine.
1977
Evidence for Reduced Catabolism by the Antiglucocorticoid RU 38486 in Acutely Uremic Rats
1987
Does acrolein contribute to the cytotoxicity of cyclophosphamide?
1980
Mass spectrometric characterization of activatedN-(2-chloroethyl)amido oxazaphosphorine derivatives
1977
Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs1
2000
The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.
1976
Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides
1979
Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds.
1976
Glufosfamide
2000
Proteases and other catabolic factors in renal failure.
1987
Tolerability and pharmacokinetics of single and multiple doses of azelastine hydrochloride in elderly volunteers.
1995
Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.
1976
Die indirekte Wirkung von Röntgenstrahlen auf Aminosäuren
1963
New metabolic pathways of alpha-lipoic acid.
2001
Tolerability, pharmacokinetics and dose linearity of azelastine hydrochloride in healthy subjects.
1994
Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
1976